Los Angeles Capital Management LLC Esperion Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $28.5 Billion
- Q3 2025
A detailed history of Los Angeles Capital Management LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 48,172 shares of ESPR stock, worth $139,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,172
Previous 48,172
-0.0%
Holding current value
$139,698
Previous $47,000
170.21%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ESPR
# of Institutions
215Shares Held
114MCall Options Held
643KPut Options Held
769K-
Black Rock Inc. New York, NY14MShares$40.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$35.1 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.75MShares$28.3 Million0.51% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT7.06MShares$20.5 Million0.1% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.4 Million7.68% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $193M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...